Reshape Lifesciences Stock Alpha and Beta Analysis
| RSLS Stock | USD 5.68 0.07 1.22% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ReShape Lifesciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in ReShape Lifesciences over a specified time horizon. Remember, high ReShape Lifesciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ReShape Lifesciences' market risk premium analysis include:
Beta 0.3 | Alpha (0.63) | Risk 6.95 | Sharpe Ratio (0.07) | Expected Return (0.45) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ReShape |
ReShape Lifesciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ReShape Lifesciences market risk premium is the additional return an investor will receive from holding ReShape Lifesciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ReShape Lifesciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ReShape Lifesciences' performance over market.| α | -0.63 | β | 0.30 |
ReShape Lifesciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ReShape Lifesciences' Buy-and-hold return. Our buy-and-hold chart shows how ReShape Lifesciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.ReShape Lifesciences Market Price Analysis
Market price analysis indicators help investors to evaluate how ReShape Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ReShape Lifesciences shares will generate the highest return on investment. By understating and applying ReShape Lifesciences stock market price indicators, traders can identify ReShape Lifesciences position entry and exit signals to maximize returns.
ReShape Lifesciences Return and Market Media
The median price of ReShape Lifesciences for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 5.68 with a coefficient of variation of 25.78. The daily time series for the period is distributed with a sample standard deviation of 1.71, arithmetic mean of 6.62, and mean deviation of 1.49. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ReShape Lifesciences announces 1-for-58 reverse stock split | 09/19/2024 |
2 | Acquisition by Thomas Stankovich of 1000 shares of ReShape Lifesciences at 0.9 subject to Rule 16b-3 | 09/20/2024 |
3 | Trend Tracker for - Stock Traders Daily | 09/26/2024 |
4 | Disposition of tradable shares by Thomas Stankovich of ReShape Lifesciences at 0.25 subject to Rule 16b-3 | 10/11/2024 |
5 | Reshape Lifesciences Inc Q3 2024 Earnings Call Highlights Revenue Growth and Strategic ... | 11/15/2024 |
6 | Disposition of 2699 shares by Bandy Barton P. of ReShape Lifesciences at 0.96 subject to Rule 16b-3 | 11/20/2024 |
7 | Disposition of tradable shares by Thomas Stankovich of ReShape Lifesciences at 0.17 subject to Rule 16b-3 | 11/22/2024 |
About ReShape Lifesciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ReShape or other stocks. Alpha measures the amount that position in ReShape Lifesciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.51 | 2.3 | 1.85 | 1.95 | Days Of Inventory On Hand | 208.7 | 296.98 | 436.25 | 414.44 |
ReShape Lifesciences Upcoming Company Events
As portrayed in its financial statements, the presentation of ReShape Lifesciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ReShape Lifesciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ReShape Lifesciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ReShape Lifesciences. Please utilize our Beneish M Score to check the likelihood of ReShape Lifesciences' management manipulating its earnings.
| 23rd of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with ReShape Lifesciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.